155 related articles for article (PubMed ID: 8701950)
1. Microangiopathic hemolytic anemia complicating FK506 (tacrolimus) therapy.
Mach-Pascual S; Samii K; Beris P
Am J Hematol; 1996 Aug; 52(4):310-2. PubMed ID: 8701950
[TBL] [Abstract][Full Text] [Related]
2. Microangiopathic haemolytic anaemia and thrombocytopenia following lung volume reduction surgery in a single lung transplant recipient on maintenance tacrolimus (FK506) therapy.
Reid DW; Street A; Mansfield D; Chin W; Cole-Sinclair M; Williams TJ; Snell GI
Respirology; 2003 Jun; 8(2):243-5. PubMed ID: 12753543
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus-related posttransplant lymphoproliferative disorder presenting as autoimmune hemolytic anemia.
DiGiuseppe JA; Bastacky SI; Shirey RS; Silberman MA; Hutchins GM; Ness PM
Arch Pathol Lab Med; 1996 Mar; 120(3):282-5. PubMed ID: 8629906
[TBL] [Abstract][Full Text] [Related]
4. Impact of changing immunosuppressive monotherapy from Cyclosporin A to Tacrolimus in long-term, stable liver transplant recipients.
Ott R; Bussenius-Kammerer M; Reck T; Koch CA; Kissler H; Hohenberger W; Müller V
Transpl Int; 2004 Jan; 17(1):39-43. PubMed ID: 14504723
[TBL] [Abstract][Full Text] [Related]
5. Microangiopathic Hemolytic Anemia Associated with the use of both Cyclosporin A and FK506 (Tacrolimus) in the Same Patient.
Murphy PT; Casey MC; Manachi M; Hutchinson RM
Hematology; 1997; 2(3):215-7. PubMed ID: 27406865
[TBL] [Abstract][Full Text] [Related]
6. Blood tacrolimus concentrations in bone marrow transplant patients undergoing plasmapheresis.
Hale GA; Reece DE; Munn RK; Kniska AB; Phillips GL
Bone Marrow Transplant; 2000 Feb; 25(4):449-51. PubMed ID: 10723590
[TBL] [Abstract][Full Text] [Related]
7. Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment.
Oran B; Donato M; Aleman A; Hosing C; Korbling M; Detry MA; Wei C; Anderlini P; Popat U; Shpall E; Giralt S; Champlin RE
Biol Blood Marrow Transplant; 2007 Apr; 13(4):469-77. PubMed ID: 17382253
[TBL] [Abstract][Full Text] [Related]
8. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
[TBL] [Abstract][Full Text] [Related]
9. New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.
Wagner K; Webber SA; Kurland G; Boyle GJ; Miller SA; Cipriani L; Griffith BP; Fricker FJ
J Heart Lung Transplant; 1997 Mar; 16(3):275-82. PubMed ID: 9087870
[TBL] [Abstract][Full Text] [Related]
10. Experience of FK506 immune suppression in pediatric heart transplantation: a study of long-term adverse effects.
Asante-Korang A; Boyle GJ; Webber SA; Miller SA; Fricker FJ
J Heart Lung Transplant; 1996 Apr; 15(4):415-22. PubMed ID: 8732602
[TBL] [Abstract][Full Text] [Related]
11. Administration of tacrolimus in 50 liver transplantation patients.
Ye QF; Ruzig MA; Gong NQ
Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):492-4. PubMed ID: 14607673
[TBL] [Abstract][Full Text] [Related]
12. Late-onset tacrolimus-associated cerebellar atrophia in a heart transplant recipient.
Kaczmarek I; Schmauss D; Sodian R; Beiras-Fernandez A; Oberhoffer M; Daebritz S; Schoenberg SO; Reichart B
J Heart Lung Transplant; 2007 Jan; 26(1):89-92. PubMed ID: 17234523
[TBL] [Abstract][Full Text] [Related]
13. Conversion of cyclosporine A to tacrolimus following heart transplantation.
Mathieu P; Carrier M; White M; Pellerin M; Perrault LP; Pelletier G; Pelletier LC
Can J Cardiol; 1999 Nov; 15(11):1229-32. PubMed ID: 10579737
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus (FK 506)-induced hemolytic uremic syndrome after heart transplantation.
Walder B; Ricou B; Suter PM
J Heart Lung Transplant; 1998 Oct; 17(10):1004-6. PubMed ID: 9811409
[TBL] [Abstract][Full Text] [Related]
15. Tacrolimus (FK506)-induced cerebral blindness following bone marrow transplantation.
Devine SM; Newman NJ; Siegel JL; Joseph GJ; Geis TC; Schneider JA; Geller RB; Wingard JR
Bone Marrow Transplant; 1996 Sep; 18(3):569-72. PubMed ID: 8879619
[TBL] [Abstract][Full Text] [Related]
16. Treatment of mitomycin-associated microangiopathic hemolytic anemia with vincristine.
Grem JL; Merritt JA; Carbone PP
Arch Intern Med; 1986 Mar; 146(3):566-8. PubMed ID: 3954531
[TBL] [Abstract][Full Text] [Related]
17. FK506-associated thrombotic microangiopathy: report of two cases and review of the literature.
Trimarchi HM; Truong LD; Brennan S; Gonzalez JM; Suki WN
Transplantation; 1999 Feb; 67(4):539-44. PubMed ID: 10071024
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppression-induced leukoencephalopathy from tacrolimus (FK506).
Small SL; Fukui MB; Bramblett GT; Eidelman BH
Ann Neurol; 1996 Oct; 40(4):575-80. PubMed ID: 8871576
[TBL] [Abstract][Full Text] [Related]
19. Microangiopathic hemolytic anemia secondary to cyclosporine.
Alonso-Santor JE; Gutierrez-Zufiaurre JL; Pérez-Castrillón JL
Ann Pharmacother; 2004 May; 38(5):903. PubMed ID: 14996994
[No Abstract] [Full Text] [Related]
20. [Clinical study of tacrolimus in postoperative treatment of patients with renal transplantation for diabetic end-stage renal disease].
Yu LX; Shan HT; Fu SJ; Du CF; Ma JJ; Xu J; Deng WF; Wang YB
Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1146-8. PubMed ID: 14625173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
